Twitter-1950934517092340154

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-31
Post ID
1950934517092340154

We're celebrating the bright minds who bring fresh energy, curiosity, and ideas to our team. Hear what our interns have to say about their experience at AtriCure! <a href="https://twitter.com/hashtag/InternDay?src=hashtag_click&quot; target="_blank">#InternDay</a>

Post image URL
https://pbs.twimg.com/media/GxMclsOXwAEiEWc.png
Post URL
https://t.co/jm95mEgVCK
Post creted timestamp

LinkedIn-EUROPE-urn:li:share:7356702998539997184

Submitted by ryadav-admin on
Feed type
LinkedIn - Europe
Post created date
1753974676
Post ID
urn:li:share:7356702998539997184

Join our expert-led Minimal Access Concomitant Course (MACC) on December 10 for a focused day of advanced surgical training:​

- Practice AF lesion sets and LAA management using the AtriClip®
- Train in a minimal access hands-on​
- Learn from leading surgeons through interactive lectures​

Spaces are limited – secure your place now.​
​
Register here: <a href="https://lnkd.in/eGneYAaB&quot; target="_blank">https://lnkd.in/eGneYAaB</a&gt;

Post image URL
https://media.licdn.com/dms/image/v2/D4E22AQFx2vEBiq71sw/feedshare-shrink_800/B4EZhhCZJAHgAg-/0/1753974675298?e=1756944000&v=beta&t=05HzjK4k_AjH_Bp_LPvbemZ2LjjAy8nInAHMrMp-TkQ
Post URL
https://www.linkedin.com/feed/update/urn:li:share:7356702998539997184
Post creted timestamp

Facebook-171059586426348_1347258754070595

Submitted by ryadav-admin on
Feed type
Facebook
Post created date
2025-07-31T15:00:58+0000
Post ID
171059586426348_1347258754070595

We're celebrating the bright minds who bring fresh energy, curiosity, and ideas to our team. Hear what our interns have to say about their experience at AtriCure! <a href="https://www.facebook.com/hashtag/InternDay&quot; target="_blank">#InternDay</a>

Post image URL
https://scontent-iad3-2.xx.fbcdn.net/v/t39.30808-6/525513236_1347258430737294_2981203367575265398_n.jpg?stp=dst-jpg_p720x720_tt6&_nc_cat=111&ccb=1-7&_nc_sid=127cfc&_nc_ohc=ZGVhgdxLTnEQ7kNvwHCzJn-&_nc_oc=AdnTeQUGb0zzoHYlOFbUwehvoX_t64JZt8I4vltlL0bD6bfoQuMBwkUgt9nDo2w0nbM&_nc_zt=23&_nc_ht=scontent-iad3-2.xx&edm=AKIiGfEEAAAA&_nc_gid=prT3wfzUnzAXYXXuKcu6-w&oh=00_AfSU8JOn3A9O0VBcSzJuIn6e08V27cQmtDCZ_0khj7zUmw&oe=689269A4
Post URL
https://www.facebook.com/513124590817353/posts/1347258754070595
Post creted timestamp

Twitter-1950324217636958342

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-29
Post ID
1950324217636958342

Our Q2 results are in—and they reflect our continued momentum.
 
Read the earnings report here: <a href="https://t.co/dDPHxDzMhp&quot; target="_blank">https://t.co/dDPHxDzMhp</a&gt;
 
<a href="https://twitter.com/hashtag/Earnings?src=hashtag_click&quot; target="_blank">#Earnings</a> <a href="https://twitter.com/hashtag/FinancialResults?src=hashtag_click&quot; target="_blank">#FinancialResults</a>

Post image URL
https://pbs.twimg.com/media/GxDxieuXkAAqLbq.png
Post URL
https://t.co/U9ntM0Y2lJ
Post creted timestamp

Twitter-1950293595153391765

Submitted by ryadav-admin on
Feed type
Twitter-AtricureCEO
Post created date
2025-07-29
Post ID
1950293595153391765

Our stellar results reflect the power of innovation and the growing impact of our expanding portfolio, particularly in our AtriClip platform and cryoSPHERE device offerings.

Post URL
https://t.co/oKJolCfb9Z
Post creted timestamp

Twitter-1950209840015380491

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-29
Post ID
1950209840015380491

10–20% of CABG patients have Afib, yet CABG has the lowest rate of surgical ablation—leaving many patients undertreated.​​

The impact?​​

Increased stroke risk​ and reduced long-term survival​.

Post video URL
https://video.twimg.com/ext_tw_video/1950209761208676352/pu/vid/avc1/320x570/C7L1snry5TL_OzrJ.mp4?tag=12
Post URL
https://t.co/gsd0iu96KS
Post creted timestamp

Twitter-1949899000808649004

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-28
Post ID
1949899000808649004

Join us for an upcoming workshop designed for advanced practice providers, PAs, RNs and NPs to explore patient selection, procedural techniques, care team collaboration, and more.​

Register at: <a href="https://t.co/ezXgANn9k2&quot; target="_blank">https://t.co/ezXgANn9k2</a&gt; ​
​
<a href="https://twitter.com/hashtag/MedEd?src=hashtag_click&quot; target="_blank">#MedEd</a> <a href="https://twitter.com/hashtag/Afib?src=hashtag_click&quot; target="_blank">#Afib</a>

Post video URL
https://video.twimg.com/ext_tw_video/1949898920986816512/pu/vid/avc1/320x568/pCJ5NXZ8JPia8oN0.mp4?tag=12
Post URL
https://t.co/ZjHHMwBSdH
Post creted timestamp

Twitter-1948397942349480245

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-24
Post ID
1948397942349480245

Pain doesn’t stop at discharge, and managing it takes a coordinated team. From the O.R. through recovery, transitional pain is a key phase requiring a multidisciplinary approach to support better outcomes.​
​
Learn more about transitional pain: <a href="https://t.co/rbGp7fDgpa&quot; target="_blank">https://t.co/rbGp7fDgpa</a&gt;

Post video URL
https://video.twimg.com/ext_tw_video/1948397787969679360/pu/vid/avc1/320x570/WGR4yRKl8ZeeVxaX.mp4?tag=12
Post URL
https://t.co/zYRoBpB5gd
Post creted timestamp

Twitter-1948035545008922752

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2025-07-23
Post ID
1948035545008922752

Individuals with symptomatic IST typically have heart rates greater than 100 bpm even with minimal activity. For those who don’t respond to medications, the HEAL-IST clinical trial is evaluating a new hybrid ablation procedure as a potential treatment.​ Learn more:

Post image URL
https://pbs.twimg.com/media/GwjQANWXcAETz9G.png
Post URL
https://t.co/gwQDXBLpcw
Post creted timestamp

Facebook-171059586426348_1340230991440038

Submitted by ryadav-admin on
Feed type
Facebook
Post created date
2025-07-23T15:00:37+0000
Post ID
171059586426348_1340230991440038

Individuals with symptomatic IST typically have heart rates greater than 100 beats per minute even with minimal activity. ​
​
The HEAL-IST Trial is currently enrolling patients to evaluate whether a hybrid sinus node sparing procedure is a safe and effective treatment option for symptomatic and drug-resistant IST patients.​

See candidate qualifications at: heal-ist.com <a href="https://www.facebook.com/hashtag/

IST" target="_blank">

#IST</a> <a href="https://www.facebook.com/hashtag/InnapropriateSinusTachycardia&quot; target="_blank">#InnapropriateSinusTachycardia</a> <a href="https://www.facebook.com/hashtag/ClinicalTrial&quot; target="_blank">#ClinicalTrial</a>

Post image URL
https://scontent-iad3-1.xx.fbcdn.net/v/t39.30808-6/521895844_1340230934773377_3668537340852190252_n.jpg?stp=dst-jpg_p720x720_tt6&_nc_cat=102&ccb=1-7&_nc_sid=127cfc&_nc_ohc=KXkCTCpg7VYQ7kNvwGPOTyJ&_nc_oc=AdmaEFcvFWgurkq7020-4zM469ygONjCqR65EuGC9TyW0E_EkqIQX7dic39Wkq0_KUU&_nc_zt=23&_nc_ht=scontent-iad3-1.xx&edm=AKIiGfEEAAAA&_nc_gid=prT3wfzUnzAXYXXuKcu6-w&oh=00_AfSKLGdw4R1NcP04dut7wGscp1VRL4nCtL--Vu2_O6lMdQ&oe=68928721
Post URL
https://www.facebook.com/513124590817353/posts/1340230991440038
Post creted timestamp
Subscribe to
© 2025 Atricure, Inc. All Rights Reserved.